Annals of Clinical Biochemistry > Volume 45, Number 3 > Pp. 275-288

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tate, J. R Articles by Carter, A. Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Original Articles

The determination of the 99th centile level for troponin assays in an Australian reference population

Jillian R Tate¹, Wendy Ferguson¹, Renze Bais², Karam Kostner³, Thomas Marwick³ and Andrew Carter¹

¹ Chemical Pathology Department, Pathology Queensland, Royal Brisbane and Women's Hospital, Herston QLD 4029, Australia; ² Clinical Biochemistry, PaLMS, Royal North Shore Hospital, Sydney NSW 2065, Australia; ³ Department of Medicine, University of Queensland, Princess Alexandra Hospital, Brisbane QLD 4102, Australia

Corresponding author: Ms Jillian Tate. Email: jill_tate{at}health.qld.gov.au

Background: Current guidelines for the diagnosis and risk assessment of patients presenting with myocardial infarction recommend a single decision cut-off point for cardiac troponin (cTn) based on the 99th centile of a reference population. The 99th centile level for eight troponin assays was determined in an apparently cardio-healthy Australian reference population.

Methods: Nine laboratories measured troponin in serum and plasma collected from 111 reference individuals. An imprecision profile was determined using up to 10 serum samples analysed on 10 separate days. Method comparison using 100 routinely tested plasma samples was performed to estimate method concordance.

Results: Generally 99th centile values determined in this study were lower than, or the same as manufacturers' levels, except for cTnI by Architect (0.020 vs. 0.012 µg/L), and imprecision at the 99th centile was 20% coefficient of variation (CV) or higher. Troponin concentrations at 10% CV were greater than those quoted in the manufacturer's package insert except by AxSYM, 0.06 vs. 0.16 µg/L cTnI, and by E-170, 0.02 vs. 0.03 µg/L cTnT. In the method comparison 74, 70, 65, 75, 58, 66, 58 and 77 samples measured by Access, Architect, AxSYM, Centaur, Dimension RxL, E-170, i-STAT and Vitros ECi assays, respectively, had troponin concentrations above the study 99th centile.

Conclusions: Depending on the selected reference population for troponin, there is likely to be variability in the 99th centile as shown in this study. Some differences in sample concordance at the 99th centile cut-off were observed between cTn methods and may result in different clinical classification.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A T George, A Brain, and J Tovey Troponin I and colonoscopy Ann Clin Biochem, September 1, 2009; 46(5): 427 - 428. [Full Text] [PDF]

				J. H Barth Reference ranges still need further clarity Ann Clin Biochem, January 1, 2009; 46(1): 1 - 2. [Full Text] [PDF]

				A. Mingels, L. Jacobs, E. Michielsen, J. Swaanenburg, W. Wodzig, and M. van Dieijen-Visser Reference Population and Marathon Runner Sera Assessed by Highly Sensitive Cardiac Troponin T and Commercial Cardiac Troponin T and I Assays Clin. Chem., January 1, 2009; 55(1): 101 - 108. [Abstract] [Full Text] [PDF]